FREE WEBINAR: Protecting Clinic Patients from Counterfeit Drugs
Protecting Clinic Patients From Counterfeit Drugs
Every patient should feel secure the medicines they take are of the highest quality. But counterfeit drugs are a growing public health threat that is denying patients medicines that can alleviate suffering and save lives.
The Partnership for Safe Medicines invite you to join us on Tuesday, November 29 from 1-2 p.m. (Eastern Time) for a free webinar on protecting clinic patients from counterfeit drugs. Counterfeit drug expert Bryan A. Liang, Ph.D., M.D., J.D., will provide clinic employees with valuable insights into this public health threat and share ways in which they can keep patients protected from counterfeit drugs.
Please visit https://www3.gotomeeting.com/register/706920470 to register for this webinar. For more information, please contact Deborah Danuser at 202-591-4043 or deborah@safemedicines.org.
About Bryan A. Liang, Ph.D., M.D., J.D.
Dr. Liang is the Executive Director and E. Donald Shapiro Distinguished Professor of Health Law, Institute of Health Law Studies, California Western School of Law; Co-Director and Adjunct Associate Professor of Anesthesiology, San Diego Center for Patient Safety, University of California San Diego School of Medicine; Adjunct Associate Professor of Public Health, Global Emergency Preparedness and Response Program, Graduate School of Public Health at San Diego State University; and Adjunct Professor of Aviation, Western Michigan University College of Aviation. He also serves as the Vice President for the Partnership for Safe Medicines.
About the Partnership for Safe Medicines (PSM)
Comprised of more than 65 non-profit organizations, the Partnership for Safe Medicines is a public health group committed to the safety of prescription drugs and protecting consumers against counterfeit, substandard or otherwise unsafe medicines. PSM can be found on Facebook (http://www.facebook.com/SafeMedicines), Twitter (@safemedicines), and the web at www.safemedicines.org.
Want to get a summary of global counterfeit drug news emailed to you every week? Sign up for our email list!
